OR WAIT null SECS
June 19, 2019
The company is voluntarily recalling all unexpired products that are intended to be sterile because of a lack of sterility assurance.
June 14, 2019
The Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom has issued a drug alert concerning a class 2 medicines recall of paracetamol tablets.
May 30, 2019
The company is voluntarily recalling Amikacin Sulfate Injection, USP, 1g/4 mL (250mg/mL), and Prochlorperazine Edisylate Injection, USP, 10mg/2mL (5mg/mL), to the consumer level because microbial growth was detected.
May 17, 2019
TraceLink will participate in the agency’s Pilot Project Program under the Drug Supply Chain Security Act.
The agency is reviewing Xeljanz (tofacitinib) because of the risk of blood clots in the lungs.
May 15, 2019
The company is recalling the lots because of possible peanut flour contamination.
May 03, 2019
The agency is updating its warning requirements for eszopiclone, zaleplon, and zolpidem after reports of complex sleep behaviors.
The company is recalling one lot of Mycophenolate Mofetil for Injection, USP because of glass fragments found in a vial after reconstitution.
May 02, 2019
The company is recalling one lot of Ketorolac Tromethamine Injection, USP, 60mg/2mL because of a lack of sterility assurance.
May 01, 2019
The company is voluntarily recalling the product due to difficulties with the delivery system.